Log In
Print this Print this

Xpresys Lung

  Manage Alerts
Collapse Summary General Information
Company Integrated Diagnostics Inc.
DescriptionNon-invasive blood test that measures the relative abundance of proteins from multiple lung cancer disease pathways using multiple reaction monitoring mass spectroscopy
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsDifferentiate between benign and malignant lung nodules
Regulatory Designation


Caprion Proteomics Inc.

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today